Antithrombin activity of surface-bound heparin studied under flow conditions
- PMID: 8557728
- DOI: 10.1002/jbm.820291013
Antithrombin activity of surface-bound heparin studied under flow conditions
Abstract
Polyacrylamide-grafted polyetherurethane sheets were modified by end-point and multipoint attachment of heparin. The surface-bound heparin was firmly attached. No release of heparin activity could be detected when the surface was rinsed at a wall shear rate of 2000 s-1. Uptake of antithrombin and thrombin inactivation were investigated under well-defined flow conditions by the use of a spinning device with an attached disk-shaped heparinized surface. It is demonstrated that the rate of thrombin inactivation at the antithrombin-heparin surface equals the maximal rate of transport of thrombin toward the surface when the surface coverage of antithrombin exceeds 10 pmol/cm2. This result indicates that a higher intrinsic catalytic efficiency of a surface does not necessarily result in a higher antithrombin activity. We varied the heparin content of the surfaces between 0 and 35 micrograms/cm2 by increasing the number of functional groups to which heparin could be covalently attached. The uptake of antithrombin increased with the heparin content of the surface, but the stoichiometry decreased from 2 to 0.5 pmol antithrombin/micrograms heparin. Apparently, antithrombin could not bind to heparins buried in the poly(acrylamide) layer. The rate of thrombin inactivation at surfaces with low heparin content (2 micrograms/cm2) fells below the transport limit of thrombin and became proportional with the heparin content of the surface. Although the contribution of surface-bound heparin to the neutralization of fluid-phase thrombin was found to be negligible compared with the effect of fluid-phase antithrombin at physiologic relevant concentrations, these heparinized surfaces markedly delayed the onset of thrombin generation in platelet-rich plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.Thromb Haemost. 1993 Aug 2;70(2):289-93. Thromb Haemost. 1993. PMID: 8236137
-
Covalently-bound heparin makes collagen thromboresistant.Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):613-7. doi: 10.1161/01.ATV.0000116026.18945.66. Epub 2004 Jan 5. Arterioscler Thromb Vasc Biol. 2004. PMID: 14707039
-
Inhibition of prothrombinase by antithrombin-heparin at a macroscopic surface.Thromb Haemost. 1995 Apr;73(4):648-53. Thromb Haemost. 1995. PMID: 7495073
-
The mechanisms of action of alpha- and beta-isoforms of antithrombin.Blood Coagul Fibrinolysis. 1998 Nov;9 Suppl 3:S7-10. Blood Coagul Fibrinolysis. 1998. PMID: 10102493 Review.
-
Development of platelet contractile force as a research and clinical measure of platelet function.Cell Biochem Biophys. 2003;38(1):55-78. doi: 10.1385/CBB:38:1:55. Cell Biochem Biophys. 2003. PMID: 12663942 Review.
Cited by
-
Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor.Ann Biomed Eng. 2016 Apr;44(4):1072-84. doi: 10.1007/s10439-015-1377-5. Epub 2015 Jul 14. Ann Biomed Eng. 2016. PMID: 26168717 Free PMC article.
-
The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts.Biomaterials. 2013 Jan;34(1):30-41. doi: 10.1016/j.biomaterials.2012.09.046. Epub 2012 Oct 12. Biomaterials. 2013. PMID: 23069711 Free PMC article.
-
Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.Elife. 2019 Aug 22;8:e46840. doi: 10.7554/eLife.46840. Elife. 2019. PMID: 31436532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical